Trial intelligence / Profile preview

Magnesium Supplementation for Children With Drug Resistant Idiopathic Epilepsy

NCT02982824Completed

Sponsor
Ain Shams University
Start
Sep 2016
Primary completion
Feb 2017
Countries
1
01

Overview

Randomised trial (3 arms), sponsored by Ain Shams University. Primary endpoints: Seizure control at 6 months and Intelligence Quotient at 6 months. Started Sep 2016; status: completed.

Beyond the preview

Go deeper on NCT02982824.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02982824.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call